When new facts are brought to their attention, the competent authorities shall examine and, as appropriate, amend the classification of a medicinal product by applying the criteria listed in Article 71.
Art. 74 Directive (EU) 2001/83
Opinion of Advocate General Bot delivered on 12 June 2019. VIPA Kereskedelmi és Szolgáltató Kft. v Országos Gyógyszerészeti és Élelmezés-egéDecision
Title VI of that directive, entitled ‘Classification of medicinal products’, contains Articles 70 to 75. Article 70 provides: ‘1. When a marketing authorisation is granted, the competent authorities shall specify the classification …
12 Jun 2019 · 62018CC0222
Directive (EU) 2004/27Lawamends
Judgment of the Court (Fifth Chamber) of 18 September 2019. VIPA Kereskedelmi és Szolgáltató Kft. v Országos Gyógyszerészeti és Élelmezés-egDecision
Title VI of that directive, entitled ‘Classification of Medicinal Products’, includes Articles 70 to 75 of the directive. Article 70 provides: ‘1. When a marketing authorisation is granted, the competent authorities shall specify the …
18 Sep 2019 · 62018CJ0222
BVerwG, Urteil vom 12. September 2019 - 3 C 3/18Decision
Nach Art. 74 der Richtlinie 2001/83/EG des Europäischen Parlaments und des Rates vom 6. November 2001 zur Schaffung eines Gemeinschaftskodexes für Humanarzneimittel (ABl. L 311 S. 67), zuletzt geändert durch Verordnung (EU) 2019/5 des …
12 Sep 2019 · WBRE201900874
Changed on 30 Apr 2004
On the occasion of the five-yearly renewal of the marketing authorization or when When new facts are brought to their noticeattention, the competent authorities shall examine and, as appropriate, amend the classification of a medicinal product, by applying the criteria listed in Article 71.
- 30 Apr 2004 – todayin force
- 6 Nov 2001 – 30 Apr 2004earlier wording
Versions are held from 6 Nov 2001; the article may be older.